NK2R signaling governs intestinal lipid mobilization and mucosal inflammation
Authors:
- Pedro A. PerezPPPedro A. Perez
- Chung-Chih LiuCLChung-Chih Liu
- Alessandra FerrariAFAlessandra Ferrari
- Nicole LittlejohnNLNicole Littlejohn
- John Paul KennellyJKJohn Paul Kennelly
- Emma RobinsonEREmma Robinson
- Vân T B Nguyen-TranVNVân T B Nguyen-Tran
- Jon AthanacioJAJon Athanacio
- Sean B JosephSJSean B Joseph
- Zaid AmsoZAZaid Amso
- Peter TontonozPTPeter Tontonoz
- Supriya SrinivasanSSSupriya Srinivasan
Preprint
Abstract
Neuropeptidergic control of lipid metabolism is conserved and increasingly implicated in metabolic diseases, but receptor-level mechanisms remain unclear. Here we identify the neurokinin-2 receptor (NK2R) as a central node linking tachykinin signals to intestinal lipid mobilization, epithelial composition, and mucosal inflammation. Across complementary genetic and pharmacological perturbations, modulation of NK2R drives bidirectional effects. Loss or blockade of NK2R increases postprandial triglyceridemia and expands intestinal lipid stores, whereas agonism suppresses chylomicron output, reduces adiposity, and improves glycemia in diet-induced obesity. Transcriptomic and cellular analyses indicate coordinated upregulation of lipid-metabolic programs with a concomitant dampening of immune pathways in the absence of NK2R, accompanied by sex-specific remodeling of secretory lineages and male-biased protection from colitis. NK2R signaling also shaped the fecal microbiota in a genotype- and diet-dependent manner, highlighting crosstalk among neuropeptide signaling, epithelial physiology, and host-microbe interactions. These findings position NK2R as a molecular switch for intestinal lipid handling and mucosal inflammation and suggest that NK2R-targeted agonists or antagonists could be deployed as context- and sex-dependent therapeutic strategies for metabolic disease and inflammatory bowel disease.Keywords
All Related Versions
- Published version: eLife, 15.
This publication has 86 references indexed in Scilit:
- Neurokinin receptors in drug and alcohol addictionBrain Research, 2020
- Gut-Innervating Nociceptor Neurons Regulate Peyer’s Patch Microfold Cells and SFB Levels to Mediate Salmonella Host DefenseCell, 2020
- Six‐Week High‐Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male RatsLipids, 2019
- Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in miceThe International Journal of Biochemistry & Cell Biology, 2019
- Substance P and pain chronicityCell and tissue research, 2018
- Epithelial IL-18 Equilibrium Controls Barrier Function in ColitisCell, 2015
- Dextran Sulfate Sodium (DSS)‐Induced Colitis in MiceCurrent Protocols in Immunology, 2014
- Substance P Antagonists as a Novel Intervention for Brain Edema and Raised Intracranial Pressure2013
- Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in humanAutonomic Neuroscience, 2006
- NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouseBrain Structure and Function, 2000